ECHO IQ
Über ECHOIQ LIMITED
EchoIQ Limited is an Australia-based artificial intelligence (AI) and medical technology company. The Company uses AI-driven technology and software to improve decision-making in cardiology. The principal activity of the Company is the development of AI software that aids in predicting Aortic Stenosis heart condition. The Company’s EchoSolv platform harnesses AI-driven analysis of echocardiographic data to assist clinicians in detecting aortic stenosis and other conditions. Its EchoSolv product allows users to assess echocardiographic studies against diagnostic guidelines for structural heart conditions. EchoSolv automatically identifies patients at risk of structural heart disease. EchoSolv improves the standard clinical workflow associated with diagnosis and treatment. The Company’s subsidiaries include HWH Software Pty Ltd, Echo IQ Global Pty Ltd and Echo IQ Incorporated.
EchoIQ Ltd Annual Shareholders Meeting
18.11.2025
02:00
Jährliche Aktionärs-Meetings
Half Year 2026 EchoIQ Ltd Earnings Release
25.02.2026
10:59
Veröffentlichungen von Geschäftszahlen